202 related articles for article (PubMed ID: 22407340)
1. Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.
Reufsteck C; Lifshitz-Shovali R; Zepp M; Bäuerle T; Kübler D; Golomb G; Berger MR
Clin Exp Metastasis; 2012 Jun; 29(5):441-56. PubMed ID: 22407340
[TBL] [Abstract][Full Text] [Related]
2. Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis.
Elazar V; Adwan H; Bäuerle T; Rohekar K; Golomb G; Berger MR
Int J Cancer; 2010 Apr; 126(7):1749-60. PubMed ID: 19739076
[TBL] [Abstract][Full Text] [Related]
3. Conditional Knockdown of Osteopontin Inhibits Breast Cancer Skeletal Metastasis.
Kovacheva M; Zepp M; Schraad M; Berger S; Berger MR
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590218
[TBL] [Abstract][Full Text] [Related]
4. Loss of MMP-2 in murine osteoblasts upregulates osteopontin and bone sialoprotein expression in a circuit regulating bone homeostasis.
Mosig RA; Martignetti JA
Dis Model Mech; 2013 Mar; 6(2):397-403. PubMed ID: 22917927
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of bone sialoprotein silencing on the adhesion ability of breast cancer cells to bone matrix].
Wang L; Wang J; Yang D; Yang C; Xia B; Wang J; Xian J
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):233-9. PubMed ID: 21650048
[TBL] [Abstract][Full Text] [Related]
6. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
[TBL] [Abstract][Full Text] [Related]
7. Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.
Kruger TE; Miller AH; Godwin AK; Wang J
Crit Rev Oncol Hematol; 2014 Feb; 89(2):330-41. PubMed ID: 24071501
[TBL] [Abstract][Full Text] [Related]
8. Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis.
Kovacheva M; Zepp M; Berger SM; Berger MR
Oncotarget; 2014 Jul; 5(14):5510-22. PubMed ID: 24980816
[TBL] [Abstract][Full Text] [Related]
9. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein.
Bäuerle T; Peterschmitt J; Hilbig H; Kiessling F; Armbruster FP; Berger MR
Int J Oncol; 2006 Mar; 28(3):573-83. PubMed ID: 16465361
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
Wang ZM; Cui YH; Li W; Chen SY; Liu TS
Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
[TBL] [Abstract][Full Text] [Related]
11. Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells.
Hahnel A; Wichmann H; Kappler M; Kotzsch M; Vordermark D; Taubert H; Bache M
Radiat Oncol; 2010 Sep; 5():82. PubMed ID: 20849637
[TBL] [Abstract][Full Text] [Related]
12. Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells.
Adwan H; Bäuerle T; Najajreh Y; Elazer V; Golomb G; Berger MR
Int J Oncol; 2004 May; 24(5):1235-44. PubMed ID: 15067347
[TBL] [Abstract][Full Text] [Related]
13. Blocking the expression of both bone sialoprotein (BSP) and osteopontin (OPN) impairs the anabolic action of PTH in mouse calvaria bone.
Bouleftour W; Bouet G; Granito RN; Thomas M; Linossier MT; Vanden-Bossche A; Aubin JE; Lafage-Proust MH; Vico L; Malaval L
J Cell Physiol; 2015 Mar; 230(3):568-77. PubMed ID: 25160656
[TBL] [Abstract][Full Text] [Related]
14. BSP gene silencing inhibits migration, invasion, and bone metastasis of MDA-MB-231BO human breast cancer cells.
Wang J; Wang L; Xia B; Yang C; Lai H; Chen X
PLoS One; 2013; 8(5):e62936. PubMed ID: 23667544
[TBL] [Abstract][Full Text] [Related]
15. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases.
Ibrahim T; Leong I; Sanchez-Sweatman O; Khokha R; Sodek J; Tenenbaum HC; Ganss B; Cheifetz S
Clin Exp Metastasis; 2000; 18(3):253-60. PubMed ID: 11315099
[TBL] [Abstract][Full Text] [Related]
16. Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro.
Boudiffa M; Wade-Gueye NM; Guignandon A; Vanden-Bossche A; Sabido O; Aubin JE; Jurdic P; Vico L; Lafage-Proust MH; Malaval L
J Bone Miner Res; 2010 Dec; 25(12):2669-79. PubMed ID: 20812227
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.
Carlinfante G; Vassiliou D; Svensson O; Wendel M; Heinegård D; Andersson G
Clin Exp Metastasis; 2003; 20(5):437-44. PubMed ID: 14524533
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.
Mandal CC; Ghosh-Choudhury N; Yoneda T; Choudhury GG; Ghosh-Choudhury N
J Biol Chem; 2011 Apr; 286(13):11314-27. PubMed ID: 21199873
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
[TBL] [Abstract][Full Text] [Related]
20. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
